Publications

5674 Results

Phase II trial of trimetrexate in advanced esophageal cancer: A Southwest Oncology Group study.

Authors
TR Fleming;TD Brown;SW Ross;JS Macdonald
Journal / Conference
Investigational New Drugs 13:363-365
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8721

Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated wtih carmustine.

Authors
M Belanich;M Pastor;T Randall;D Guerra;J Kibitel;L Alas;B Li;M Citron;P Wasserman;A White;H Eyre;K Jaeckle;S Schulman;D Rector;M Prados;S Coons;W Shapiro;D Yarosh
Journal / Conference
Cancer Research 56(4):783-788
Year
1996
Research Committee(s)
Brain
Study Number(s)
SWOG-9218

Intraperitoneal cislatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Authors
DS Alberts;PY Liu;EV Hannigan;R O'Toole;SD Williams;JA Young;EW Franklin;DL Clarke-Pearson;VK Malviya;B DuBeshter;MD Adelson;WJ Hoskins
Journal / Conference
New England Journal of Medicine 335(26):1950-1955
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8501 (INT-0051)

Prostate cancer prevention trial.

Authors
BH Zoltick
Journal / Conference
Presented at the AUAA Annual Assembly-Orlando Florida May 4-7 :
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Screening for prostate cancer: Opportunities for prevention.

Authors
IM Thompson;CA Coltman Jr
Journal / Conference
Seminars in Urologic Oncology 14(2)(Suppl.2):4-11
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Chemoprevention of prostate cancer with finasteride.

Authors
I Thompson;P Feigl;C Coltman
Journal / Conference
Principles and Practice of Oncology 10(3):1-18
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Southwest Oncology Group (SWOG)

Authors
LC Loll;CM Moinpour;P Feigl
Journal / Conference
Journal of the National Cancer Institute Monographs 20:83-85
Year
1996
Research Committee(s)
Cancer Control

A phase II trial of interferon-a and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.

Authors
L Elias;BA Blumenstein;J Kish;RC Flanigan;JL Wade;BA Lowe;JW Goodwin;ED Crawford
Journal / Conference
Cancer 78:1085-1088
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9122

Evaluation of topotecan in patients with recurrent or metastatic squamous cell carcinoma of the head and neck, a phase II Southwest Oncology Group study.

Authors
RE Smith;D Lew;GI Rodriguez;SA Taylor;JF Ensley
Journal / Conference
Investigational New Drugs 14:403-407
Year
1996
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9305 (CALGB-8984)

Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.

Authors
EA Poplin;J Jacobson;A Herskovic;TJ Panella;M Valdivieso;LF Hutchins;JS Macdonald
Journal / Conference
Cancer 78(9):1851-1856
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9060